Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $603.63 million. The enterprise value is $371.36 million.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.87 million shares outstanding. The number of shares has increased by 50.61% in one year.
| Current Share Class | 18.87M |
| Shares Outstanding | 18.87M |
| Shares Change (YoY) | +50.61% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 34.08% |
| Owned by Institutions (%) | 70.36% |
| Float | 11.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.61 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.51, with a Debt / Equity ratio of 0.02.
| Current Ratio | 18.51 |
| Quick Ratio | 18.28 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,824.29 |
Financial Efficiency
Return on equity (ROE) is -31.42% and return on invested capital (ROIC) is -21.59%.
| Return on Equity (ROE) | -31.42% |
| Return on Assets (ROA) | -20.72% |
| Return on Invested Capital (ROIC) | -21.59% |
| Return on Capital Employed (ROCE) | -39.83% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.39M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TECX has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.20% in the last 52 weeks. The beta is 0.14, so TECX's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +57.20% |
| 50-Day Moving Average | 29.04 |
| 200-Day Moving Average | 23.42 |
| Relative Strength Index (RSI) | 63.66 |
| Average Volume (20 Days) | 141,705 |
Short Selling Information
The latest short interest is 2.34 million, so 12.41% of the outstanding shares have been sold short.
| Short Interest | 2.34M |
| Short Previous Month | 2.61M |
| Short % of Shares Out | 12.41% |
| Short % of Float | 20.84% |
| Short Ratio (days to cover) | 9.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -93.04M |
| Pretax Income | -82.26M |
| Net Income | -83.49M |
| EBITDA | -91.72M |
| EBIT | -93.04M |
| Earnings Per Share (EPS) | -$4.46 |
Full Income StatementBalance Sheet
The company has $236.89 million in cash and $4.63 million in debt, giving a net cash position of $232.26 million or $12.31 per share.
| Cash & Cash Equivalents | 236.89M |
| Total Debt | 4.63M |
| Net Cash | 232.26M |
| Net Cash Per Share | $12.31 |
| Equity (Book Value) | 230.42M |
| Book Value Per Share | 12.24 |
| Working Capital | 226.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.41 million and capital expenditures -$200,000, giving a free cash flow of -$65.61 million.
| Operating Cash Flow | -65.41M |
| Capital Expenditures | -200,000 |
| Depreciation & Amortization | 1.32M |
| Net Borrowing | -476,000 |
| Free Cash Flow | -65.61M |
| FCF Per Share | -$3.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |